4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-17-036461
Options or other derivatives
- Director acquired 16,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Scadden David Director | 2017-05-27 | Grant or award · Stock option (right to buy) | +16,000 | 16,000 | D | ||
Loading xslF345X03/doc4.xml…